Breast Neoplasms Clinical Trials
There are 21 registered clinical trials for Breast Neoplasms in the TrialLens index.
Trials (21)
- Breast Cancer and Exercise Trial in Alberta N/A · AHS Cancer Control Alberta
- Prevention of Female Cancers by Optimization of Selenium Levels in the Organism. N/A · Read-Gene S.A.
- Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer Phase 2 · Bayer
- Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer N/A · Moroccan Society of Surgery
- Comparison of Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block N/A · Diskapi Yildirim Beyazit Education and Research Hospital
- A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer Phase 1 · Eisai Co., Ltd.
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence N/A · Novartis Pharmaceuticals
- A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer Phase 3 · National Cancer Institute (NCI)
- ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies N/A · University Hospital, Caen
- The Unmet Needs and the Workplace Reintegration of Breast Cancer Patients: the NEW-BreCa Project N/A · Azienda USL Reggio Emilia - IRCCS
- Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation N/A · Institut Paoli-Calmettes
- NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer Phase 2 · Midwestern Regional Medical Center
- Delphinus SoftVue Prospective Case Collection - ARM 2 N/A · Delphinus Medical Technologies, Inc.
- Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) Phase 2 · Merck Sharp & Dohme LLC
- Outcomes of Education and Counseling for BRCA1 Testing N/A · National Human Genome Research Institute (NHGRI)
- Rehabilitation on Equal Terms - The ReMig Study N/A · Lund University
- Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics N/A · First Affiliated Hospital Xi'an Jiaotong University
- Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer N/A · Fundación Santa Fe de Bogota
- Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing N/A · Taipei Medical University Hospital
- Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer Phase 2 · Xinjiang Medical University
- Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions N/A · Assistance Publique - Hôpitaux de Paris
Related landscapes
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.